Skip to content
Home/Companies/Biotech/Alveus Therapeutics
AT

Alveus Therapeutics

Biotech·US·Active·0yr hold

Alveus Therapeutics is a healthcare company, headquartered in France.

Entry
2026
Hold
0yr
Status
Active
Est. EV
–

Who owns Alveus Therapeutics?

Alveus Therapeutics is currently owned by Jeito Capital through Jeito II (2026 vintage), since 2026. Across its history, Alveus Therapeutics has been through 3 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Jeito Capital
Most recent investor
Jeito Capital
Jeito II · 2026 · VC
3 ownership periods · full history below

Key facts

HQFrance
SectorHealthcare

Ownership history

3 ownership periods

Active
Co-held by Kurma Partners, Andera Partners and Jeito Capital since 2026.
Kurma Partners
Kurma PartnersActive
2026 · present · Kurma Biofund IV · 2024 · VC
MOIC
–
Andera Partners
Andera PartnersActive
2026 · present · BioDiscovery 7 · 2025 · VC
MOIC
–
Jeito Capital
Jeito CapitalActive
2026 · present · Jeito II · 2026 · VC
MOIC
–

More from Jeito II

Other portfolio companies in the same fund.

Adcendo
Active
BiotechDenmark· 2026
Augustine Therapeutics
Active
BiotechBelgium· 2025
Azafaros
Active
BiotechNetherlands· 2025
Callio Therapeutics
Active
BiotechUS· 2025
Odyssey Therapeutics
Active
BiotechUS· 2025
Aviceda Therapeutics
Active
BiotechUS· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings